Form 4: Evolent Health Director Glass Acquires Shares in Recent Transaction

Director Russell Monroe Glass of Evolent Health, Inc. reports the acquisition of 5,400 shares of Class A Common Stock at $9.27 per share on March 6, 2025.

Summary

• On March 6, 2025, Russell Monroe Glass, a director of Evolent Health, Inc., acquired 5,400 shares of Class A Common Stock.
• The purchase price was $9.27 per share.
• Following the transaction, Glass directly owns 14,272 shares of Class A Common Stock.
• Glass also indirectly owns 6,046 shares through a trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing a stock purchase by a director. While insider purchases can be seen as a positive signal, this is a routine disclosure.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities. This filing indicates a director's recent stock purchase, which is a common occurrence.

Stakeholder Impact

• Shareholders may view the director's stock purchase as a positive sign of confidence in the company.

Key Dates